Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1-10 of 400 for multiple

Edit search filters
  1. A Study to Evaluate Safety, and Efficacy of SUVN-G3031 in Patients With Narcolepsy With and Without Cataplexy

    Scottsdale/Phoenix, AZ

  2. A Study to Analyze SAR442168 in Participants with Nonrelapsing Secondary Progressive Multiple Sclerosis

    Rochester, MN

  3. A Study to Evaluate the Safety and Effectiveness of SAR442168 Compared to Placebo in Primary Progressive Multiple Sclerosis (PPMS) Patients

    Rochester, MN

  4. Adherence in Pediatric Multiple Sclerosis

    Rochester, MN

  5. A Study to Determine the Effectiveness of Early Intensive vs. Escalation Approach to Treat Relapsing/Remitting Multiple Sclerosis

    Rochester, MN

  6. A Study of the Safety and Effectiveness of ADS-5102 in Patients with Multiple Sclerosis and a Walking Impairment

    Rochester, MN

  7. A Study to Evaluate Aspirin for Treating Multiple Sclerosis-related Fatigue

    Scottsdale/Phoenix, AZ

  8. Phase 1 Study to Evaluate the Safety of ATA188 in Subjects With Progressive and Relapsing-Remitting Multiple Sclerosis

    Scottsdale/Phoenix, AZ

  9. An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab

    Scottsdale/Phoenix, AZ

  10. A Study to Evaluate Traditional Versus Early Aggressive Therapy for Multiple Sclerosis Patients

    Rochester, MN

.

Mayo Clinic Footer